Global Immunosuppressants Market 2024-2028

Global Immunosuppressants Market 2024-2028


The immunosuppressants market is forecasted to grow by USD 4.48 bn during 2023-2028, accelerating at a CAGR of 5.19% during the forecast period. The report on the immunosuppressants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by reimbursement policies for kidney transplantation, rising prevalence of autoimmune diseases, and increasing road accidents.

Technavio's immunosuppressants market is segmented as below:

By Drug Class
  • Corticosteroids
  • Monoclonal antibodies
  • Others
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the high dependency on immunosuppressants for kidney transplantation as one of the prime reasons driving the immunosuppressants market growth during the next few years. Also, increase in use of tissue engineering for generation of implants and rise in disposable income in developing economies will lead to sizable demand in the market.

The report on the immunosuppressants market covers the following areas:
  • Immunosuppressants market sizing
  • Immunosuppressants market forecast
  • Immunosuppressants market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunosuppressants market vendors that include AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi SA, Sebela Pharmaceuticals Inc., and Viatris Inc.. Also, the immunosuppressants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Immunosuppressants Market 2018 - 2022
Historic Market Size - Data Table on Global Immunosuppressants Market 2018 - 2022 ($ billion)
4.2 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Drug Class
6.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
6.3 Corticosteroids - Market size and forecast 2023-2028
Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
6.4 Monoclonal antibodies - Market size and forecast 2023-2028
Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ billion)
Data Table on Market opportunity by Drug Class ($ billion)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
11.4 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.5 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.6 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.7 Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. - Overview
Intas Pharmaceuticals Ltd. - Product / Service
Intas Pharmaceuticals Ltd. - Key offerings
11.8 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
11.9 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.10 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.11 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Immunosuppressants Market 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits31: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Drug Class ($ billion)
Exhibits47: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits51: Chart on Geographic comparison
Exhibits52: Data Table on Geographic comparison
Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits89: Market opportunity By Geographical Landscape ($ billion)
Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2023 and 2028
Exhibits92: Overview on criticality of inputs and factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Companies covered
Exhibits96: Matrix on companies position and classification
Exhibits97: Astellas Pharma Inc. - Overview
Exhibits98: Astellas Pharma Inc. - Product / Service
Exhibits99: Astellas Pharma Inc. - Key news
Exhibits100: Astellas Pharma Inc. - Key offerings
Exhibits101: Bristol Myers Squibb Co. - Overview
Exhibits102: Bristol Myers Squibb Co. - Product / Service
Exhibits103: Bristol Myers Squibb Co. - Key news
Exhibits104: Bristol Myers Squibb Co. - Key offerings
Exhibits105: F. Hoffmann La Roche Ltd. - Overview
Exhibits106: F. Hoffmann La Roche Ltd. - Business segments
Exhibits107: F. Hoffmann La Roche Ltd. - Key news
Exhibits108: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits109: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits110: GlaxoSmithKline Plc - Overview
Exhibits111: GlaxoSmithKline Plc - Business segments
Exhibits112: GlaxoSmithKline Plc - Key news
Exhibits113: GlaxoSmithKline Plc - Key offerings
Exhibits114: GlaxoSmithKline Plc - Segment focus
Exhibits115: Intas Pharmaceuticals Ltd. - Overview
Exhibits116: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits117: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits118: Johnson and Johnson Services Inc. - Overview
Exhibits119: Johnson and Johnson Services Inc. - Business segments
Exhibits120: Johnson and Johnson Services Inc. - Key news
Exhibits121: Johnson and Johnson Services Inc. - Key offerings
Exhibits122: Johnson and Johnson Services Inc. - Segment focus
Exhibits123: Novartis AG - Overview
Exhibits124: Novartis AG - Business segments
Exhibits125: Novartis AG - Key news
Exhibits126: Novartis AG - Key offerings
Exhibits127: Novartis AG - Segment focus
Exhibits128: Pfizer Inc. - Overview
Exhibits129: Pfizer Inc. - Product / Service
Exhibits130: Pfizer Inc. - Key news
Exhibits131: Pfizer Inc. - Key offerings
Exhibits132: Sanofi SA - Overview
Exhibits133: Sanofi SA - Business segments
Exhibits134: Sanofi SA - Key news
Exhibits135: Sanofi SA - Key offerings
Exhibits136: Sanofi SA - Segment focus
Exhibits137: Viatris Inc. - Overview
Exhibits138: Viatris Inc. - Business segments
Exhibits139: Viatris Inc. - Key news
Exhibits140: Viatris Inc. - Key offerings
Exhibits141: Viatris Inc. - Segment focus
Exhibits142: Inclusions checklist
Exhibits143: Exclusions checklist
Exhibits144: Currency conversion rates for US$
Exhibits145: Research methodology
Exhibits146: Information sources
Exhibits147: Data validation
Exhibits148: Validation techniques employed for market sizing
Exhibits149: Data synthesis
Exhibits150: 360 degree market analysis
Exhibits151: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings